TrialPloS one2020

Intranasal GSK2245035, a Toll-like receptor 7 agonist, does not attenuate the allergen-induced asthmatic response in a randomized, double-blind, placebo-controlled experimental medicine study.

Hilary Siddall et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.